K. Miki

发表

Mid‐term outcome of permanent prostate iodine‐125 brachytherapy in Japanese patients

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2014, International journal of urology : official journal of the Japanese Urological Association.

Short‐term impact of androgen deprivation therapy on bone strength in castration‐sensitive prostate cancer

S. Egawa, H. Sasaki, Takahiro Kimura, 2019, International journal of urology : official journal of the Japanese Urological Association.

Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis-Targeted Agents.

S. Egawa, H. Sasaki, M. Honda, 2019, Clinical genitourinary cancer.

Author's response to reviews Title: Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial Authors:

S. Egawa, H. Sasaki, H. Yamanaka, 2010 .

Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging

S. Egawa, H. Yamada, Koichi Kishimoto, 2006, International journal of urology : official journal of the Japanese Urological Association.

Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer

S. Egawa, H. Sasaki, M. Kido, 2014, Korean journal of urology.

A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2016, BMC Cancer.

Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer

S. Egawa, H. Sasaki, Shunsuke Tsuzuki, 2020, International Journal of Clinical Oncology.

No survival benefit found after extended treatment with docetaxel for patients with castration‐resistant prostate cancer

S. Egawa, H. Sasaki, Masatoshi Tanaka, 2022 .

Earlier use of androgen receptor‐axis‐targeted drugs may improve overall survival in patients with non‐metastatic castration‐resistant prostate cancer

S. Egawa, H. Sasaki, Masatoshi Tanaka, 2018, The Prostate.

Lactate dehydrogenase predicts combined progression‐free survival after sequential therapy with abiraterone and enzalutamide for patients with castration‐resistant prostate cancer

S. Egawa, H. Sasaki, Toshihiro Yamamoto, 2017, The Prostate.

Do androgen deprivation and the biologically equivalent dose matter in low‐dose‐rate brachytherapy for intermediate‐risk prostate cancer?

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2016, Cancer Medicine.

Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)

S. Egawa, H. Sasaki, M. Kido, 2013, Journal of radiation research.

Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial

S. Egawa, H. Sasaki, Shunsuke Tsuzuki, 2016, International journal of urology : official journal of the Japanese Urological Association.

Long‐term outcomes of radical prostatectomy versus low‐dose‐rate brachytherapy in patients with intermediate‐risk prostate cancer: Propensity score matched comparison

Hiroyuki Takahashi, S. Egawa, Fumihiko Urabe, 2022, The Prostate.

Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapy

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2021, The Prostate.

Malignant mesothelioma of testicular tunica vaginalis

H. Kiyota, S. Nimura, K. Miki, 2002, International journal of urology : official journal of the Japanese Urological Association.

Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2009, The American journal of pathology.

Prognostic Significance of Prostate-Specific Antigen Persistence after Radical Prostatectomy: A Systematic Review and Meta-Analysis

S. Egawa, H. Sasaki, K. Miki, 2021, Cancers.

Lateral view dissection of the prostato‐urethral junction to reduce positive apical margin in laparoscopic radical prostatectomy

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2009, International journal of urology : official journal of the Japanese Urological Association.

Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer

S. Egawa, H. Sasaki, K. Mori, 2019, International Journal of Clinical Oncology.

The Prostate

S. Egawa, H. Sasaki, Masatoshi Tanaka, 2019 .

Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2010, BMC Cancer.

[Magnetic resonance images of hematospermia].

N. Kondo, Y. Ohishi, N. Furuta, 1998, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Clinical studies on inverted papilloma of the urinary tract].

H. Kiyota, N. Furuta, K. Miki, 1999, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Extracorporeal shock wave treatment for Peyronie’s disease using EDAP LT‐02; preliminary results

H. Kiyota, Y. Ohishi, J. Miki, 2002, International journal of urology : official journal of the Japanese Urological Association.

Retroperitoneoscopic ureterolithotomy for impacted ureteral stone

I. Ikemoto, H. Kiyota, Y. Ohishi, 2001, International journal of urology : official journal of the Japanese Urological Association.

Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system.

K. Miyasaka, K. Kishimoto, N. Furuta, 2001, Radiation medicine.

Squamous cell carcinoma of the renal pelvis with inferior vena caval extension

H. Kiyota, Y. Ohishi, K. Miki, 2000, International journal of urology : official journal of the Japanese Urological Association.

Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2014, International journal of urology : official journal of the Japanese Urological Association.

Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2021, Andrology.

[A Case of Slowly Growing Primary Malignant Lymphoma of the Epididymis].

Hiroyuki Takahashi, S. Egawa, K. Miki, 2015, Hinyokika kiyo. Acta urologica Japonica.

Prospective comparison of the efficacy of caudal versus periprostatic nerve block, both with intrarectal local anesthesia, during transrectal ultrasonography-guided prostatic needle biopsy

S. Egawa, H. Sasaki, H. Kuruma, 2017, Scandinavian journal of urology.

Does docetaxel prolong survival of patients with non‐metastatic castration‐resistant prostate cancer?

S. Egawa, Masayuki Tomita, Kagenori Ito, 2018, The Prostate.

Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study

M. Yasuda, T. Deguchi, M. Nakano, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: A comparative, randomized, two‐drug crossover study

I. Ikemoto, H. Kiyota, Y. Ohishi, 2003, International journal of urology : official journal of the Japanese Urological Association.

[RISK FACTORS FOR INTRAVESICAL RECURRENCE AFTER SURGICAL MANAGEMENT OF UROTHERIAL CARCINOMA OF THE UPPER URINARY TRACT].

S. Egawa, H. Yamada, H. Sasaki, 2015, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis.

S. Egawa, H. Sasaki, K. Mori, 2020, Urologic oncology.

Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3–4, 2020

S. Egawa, H. Sasaki, Shunsuke Tsuzuki, 2020, International Journal of Clinical Oncology.

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2016, BMC Cancer.

Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer

Hiroyuki Takahashi, S. Shariat, S. Egawa, 2021, Strahlentherapie und Onkologie.

The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation

Hiroyuki Takahashi, Shunsuke Tsuzuki, M. Honda, 2023, International Journal of Clinical Oncology.

Upfront transection and subsequent ligation of the dorsal vein complex during laparoscopic radical prostatectomy

S. Egawa, H. Sasaki, Yusuke Koike, 2010, International journal of urology : official journal of the Japanese Urological Association.

Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis

S. Egawa, H. Sasaki, M. Kido, 2021, Prostate Cancer and Prostatic Diseases.

Prognostic value of PSA bounce after definitive radiotherapy revisited

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2021, International Journal of Clinical Oncology.

Prostate‐specific antigen ‘bounce’ after permanent 125I‐implant brachytherapy in Japanese men: a multi‐institutional pooled analysis

S. Kanazawa, S. Egawa, S. Baba, 2009, BJU international.

Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer

Hiroyuki Takahashi, Shunsuke Tsuzuki, M. Honda, 2023, AntiCancer Research.

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?

Hiroyuki Takahashi, S. Egawa, M. Aoki, 2021, International Journal of Clinical Oncology.

Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial

Y. Homma, Masafumi Nakamura, S. Egawa, 2013, World Journal of Urology.

The efficacy of neoadjuvant androgen deprivation therapy as a prostate volume reduction before brachytherapy for clinically localized prostate cancer.

H. Kumon, T. Saika, S. Ebara, 2007, Acta medica Okayama.

Effect of Adequate Local Radiation Dose on Oncological Outcomes in Localized Prostate Cancer Patients Treated With Low-dose-rate Brachytherapy

Hiroyuki Takahashi, Shunsuke Tsuzuki, A. Furuta, 2023, AntiCancer Research.

Evaluation of rectal bleeding factors associated with prostate brachytherapy

H. Sasaki, Masao Kobayashi, C. Kanehira, 2009, Japanese Journal of Radiology.

[A case of adrenocortical carcinoma with masculinization, obtaining long prognosis with surgical treatment alone].

H. Kiyota, Hidenori Suzuki, Y. Ohishi, 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

1038 poster PROSTATE BRACHYTHERAPY WITH OR WITHOUT ADJUVANT ADT IN INTERMEDIATE PROSTATE CANCER: STUDY PROTOCOL

M. Aoki, K. Miki, K. Masahito, 2011 .

Results of central pathology review of prostatic biopsies in a contemporary series from a phase III, multicenter, randomized controlled trial (SHIP0804)

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2015, Pathology international.

Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate

Shunsuke Tsuzuki, K. Mori, Fumihiko Urabe, 2024, JAMA network open.

Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.

Shunsuke Tsuzuki, K. Mori, Fumihiko Urabe, 2024, Clinical genitourinary cancer.

Hiroyuki Takahashi, S. Egawa, H. Sasaki, 2010, BMC Cancer.